Conformationally restrained aromatic analogues of fosmidomycin and FR900098

Archiv der Pharmazie

Volumn 340, Issue 7, 2007, Pages 339-344

  Kurz, Thomas ^a   Schlüter, Katrin ^a   Pein, Miriam ^a   Behrendt, Christoph ^a   Bergmann, Bärbel ^b   Walter, Rolf D ^b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Conformationally restrained analogues; Fosmidomycin; Malaria tropica; Plasmodium falciparum

Indexed keywords

2,2 DIMETHYL PROPIONIC ACID (2,2 DIMETHYL PROPIONYLOXYMETHOXY) [2 [(FORMYL HYDROXY AMINO) METHYL] PHENYL] PHOSPHINOYLOXYMETHYL ESTER; 2,2 DIMETHYL PROPIONIC ACID [2 [(ACETYL HYDROXY AMINO) METHYL] PHENYL] (2,2 DIMETHYL PROPIONYLOXYMETHOXY) PHOSPHINOYLOXYMETHYL ESTER; 2,2 DIMETHYL PROPIONIC ACID [2 [(BENZOYL HYDROXY AMINO) METHYL] PHENYL] (2,2 DIMETHYL PROPIONYLOXYMETHOXY) PHOSPHINOYLOXYMETHYL ESTER; 3 (N ACETYL N HYDROXYAMINO)PROPYLPHOSPHONIC ACID; ANTIMALARIAL AGENT; BIS(PIVALOYLOXYMETHYL)ESTER DERIVATIVE; ESTER DERIVATIVE; FOSMIDOMYCIN; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; CONFORMATION; DRUG STRUCTURE; DRUG SYNTHESIS; GROWTH INHIBITION; IN VITRO STUDY; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; ESTERS; FOSFOMYCIN; INHIBITORY CONCENTRATION 50; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PRODRUGS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34547161878     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200700013     Document Type: Article

References (22)

1. B. Greenwood, T. Mutabingwa, Nature 2002, 415, 670-672.
2. S. A. Ralph, G. G. van Dooren, R. F. Waller, M. J. Crawford, et al., Nat. Rev. Microbiol. 2004, 2, 203-216.
3. T. Kuzuyama, S. Takahashi, M. Takagi, H. Seto, J. Biolog. Chem. 2000, 275, 19928-19932;
4. W. Eisenreich, F. Rohdich, A. Bacher, Trends Plant Sci. 2001, 6, 78-84;
5. M. Rohmer, Nat. Prod. Rep. 1999, 16, 565-574.
6. H. Jomaa, J. Wiesner, S. Sanderbrand, B. Altincicek, et al., Science 1999, 285, 1573-1576.
7. M. A. Missinou, S. Borrmann, A. Schindler, S. Issifou, et al., Lancet 2002, 360, 1941-1942;
8. B. Lell, R. Ruangweerayut, J. Wiesner, M. A. Missinou, et al., Antimicrob. Agents Chemother. 2003, 47, 735-738.
9. T. Kurz, K. Schlüter, U. Kaula, B. Bergmann, et al., Bioorg. Med. Chem. 2006, 14, 5121-5135;
10. K. Schlüter, T. Kurz, B. Bergmann, R. D. Walter, Eur. J. Med. Chem. 2006, 41, 1385-1397.
11. T. Kurz, D. Geffken, C. Wackendorf, Z. Naturforsch. 2003, 58b, 106-110.
12. T. Kurz, D. Geffken, C. Wackendorf, Z. Naturforsch. 2003, 58b, 457-461.
13. R. Ortmann, J. Wiesner, A. Reichenberg, D. Henschker, et al., Bioorg. Med. Chem. Lett. 2003, 13, 2163-2166;
14. R. Ortmann, J. Wiesner, A. Reichenberg, D. Henschker, et al., Arch. Pharm. Chem. Life Sci. 2005, 338, 305-314.
15. T. Kurz, D. Geftken, U. Kaula (BioAgency AG). DE 10356410A1 and WO 2005048715, 2005.
16. T. Haemers, J. Wiesner, S. V. Poecke, J. Goeman, et al., Bioorg. Med. Chem. Lett. 2006, 16, 1888-1891;
17. V. Devreux, J. Wiesner, J. L. Goeman, J. Van der Eycken, et al., J. Med. Chem. 2006, 49, 2656-2660;
18. T. Haemers, J. Wiesner, R. Busson, H. Jomaa, et al., Eur. J. Org. Chem. 2006, 16, 3856-3863.
19. T. G. Harvey, Tetrahedron 1966, 22, 2561-2564.
20. R. E. Desjardins, C. J. Canfield, J. D. Haynes, J. D. Chulay, Antimicrob. Agents Chemother. 1979, 16, 710-718.
21. R. Das Gupta, T. Krause-Ihle, B. Bergmann, I. B. Müller, et al., Antimicrob. Agents Chemother. 2005, 49, 2857-2864;
22. W. Trager, J. D. Jensen, Science 1976, 193, 673-677.